JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1986; 65:520-522
© 1986 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vender, J. S.
Right arrow Articles by Dau, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vender, J. S.
Right arrow Articles by Dau, P. C.

Heparin-Associated Thrombocytopenia

Alternative Managements

J. S. Vender, MD, E. B. Matthew, MD, I. M. Silverman, MD, H. Konowitz, MD, and P. C. Dau, MD

Received from the Departments of Anesthesiology and Medicine, Evanston Hospital, Evanston, Illinois and Northwestern University Medical School, Chicago, Illinois.

Abstract

Hepar in Associated Thrombocytopenia (HAT) is a well-described clinical entity (1–5), frequently requiring prompt cessation of heparin therapy to correct the thrombocytopenia. Previously recommended management also called for discontinuing heparin for several weeks to allow the alteration in platelet aggregation to normalize prior to the safe readministration of heparin. Discontinuation of heparin presents a challenging clinical problem in patients who have developed HAT and subsequently require urgent cardiac surgery. The case report describes the use of plasmapheresis to rapidly reverse the immunologie abnormality reportedly responsible for HAT, permitting the early use of heparin in a patient with HAT who required urgent cardiac surgery.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
F. Follis and C. A. Schmidt
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
Ann. Thorac. Surg., December 1, 2000; 70(6): 2173 - 2181.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. Cummins and E. Hill
Heparin-Induced Thrombocytopenia
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 349 - 365.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
S. Kleinschmidt and U.T. Seyfert
Heparin-Associated Thrombocytopenia (HAT)--Still a Diagnostic and Therapeutical Problem in Clinical Practice
Angiology, January 1, 1995; 46(1): 37 - 44.
[Abstract] [PDF]


Home page
J Intensive Care MedHome page
E. G. Wittels, R. D. Siegel, and E. M. Mazur
Thrombocytopenia in the Intensive Care Unit Setting
J Intensive Care Med, September 1, 1990; 5(5): 224 - 240.
[Abstract] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1986 by the International Anesthesia Research Society.